MILLIPEDE
Millipede develops a catheter-based solution to treat mitral and tricuspid regurgitation, restoring health and expanding options for physicians, and global patients.
MILLIPEDE
Industry:
Health Care Medical Wellness
Founded:
2011-01-01
Address:
Santa Rosa, California, United States
Country:
United States
Website Url:
http://www.millipedemedical.com
Total Employee:
11+
Status:
Active
Contact:
(707)524-7500
Total Funding:
49.38 M USD
Technology used in webpage:
SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy Cisco Ironport Cloud ATT DNS
Similar Organizations
AbleTo
AbleTo is a provider of virtual behavioral health care.
BetterNight
BetterNight is providing telehealth-based sleep solutions.
My Online Therapy
MyOnlineTherapy, a mobile mental health company, is the first of its kind virtual psychology clinic.
Current Employees Featured
Steven Bolling Founder @ Millipede
Founder
Founder
Investors List
Boston Scientific
Boston Scientific investment in Venture Round - Millipede
Sante Ventures
Sante Ventures investment in Series B - Millipede
Sante Ventures
Sante Ventures investment in Series A - Millipede
Official Site Inspections
http://www.millipedemedical.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Millipede"
Millipede - Crunchbase Company Profile & Funding
Millipede develops a catheter-based solution to treat mitral and tricuspid regurgitation, restoring health and expanding options for physicians, and global patients. Millipede was acquired by …See details»
Millipede Company Profile 2024: Valuation, Investors ... - PitchBook
Developer of a catheter based medical ring designed to treat mitral and tricuspid regurgitation.See details»
Millipede, Inc. - LinkedIn
Millipede, Inc. is a Medical Device company located in Santa Rosa, CA developing a transcatheter annuloplasty ring for the treatment of mitral and tricuspid regurgitation.See details»
Boston Scientific Exercises Option to Acquire Millipede, Inc.
MARLBOROUGH, Mass., Dec. 27, 2018 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire the remaining shares of Millipede, Inc, …See details»
Millipede, Inc. Announces Successful Clinical Use of the First ...
May 12, 2017 · Millipede, Inc. (www.millipedemedical.com) is based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in heart valve repair – a complete …See details»
Perfuze | Next Generation Stroke Technology
Perfuze aims to improve patient outcomes with advanced superbore aspiration technology that simplifies access and clot removal.* Located in Galway City in the West of Ireland, Perfuze was co-founded in 2018 by experienced medtech …See details»
Millipede, Inc. Announces First Implants with New …
Sep 10, 2018 · Millipede, Inc. (www.millipedemedical.com) is a privately-held medical device company based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in mitral...See details»
Boston Scientific Announces Investment and Acquisition Option …
MARLBOROUGH, Mass., Jan. 24, 2018 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced it has closed an investment and entered into an acquisition option …See details»
Boston Scientific bags option on mitral regurgitation …
Jan 25, 2018 · Boston Scientific has secured an option to buy mitral regurgitation startup Millipede. The agreement sees Boston Scientific buy $90 million of Millipede stock upfront and gain the right to acquire...See details»
Millipede Announces Successful Clinical Use Of The First
May 12, 2017 · Millipede, Inc. (www.millipedemedical.com) is based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in heart valve repair a complete …See details»
Boston Scientific completes Millipede acquisition for $325 million
Dec 27, 2018 · Medical device manufacturer Boston Scientific has exercised its option to acquire the rest of Santa Rosa, California-based company Millipede Inc. to build out its cardiac portfolio.See details»
Boston Scientific strikes $325M Millipede mitral valve repair buyout
Jan 3, 2019 · Boston Scientific has exercised its option to acquire Millipede and its experimental treatment for severe mitral regurgitation (MR) for $325 million upfront.See details»
FDA Clears Millipede 088 Access Catheter - Medical Design
Feb 16, 2023 · Perfuze, a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke, has secured its first product clearance from the U.S. …See details»
Millipede, Inc. Announces First Implants with New Integrated ICE ...
Sep 10, 2018 · SANTA ROSA, Calif., /PRNewswire/ -- Millipede, Inc., a medical device company leading the way in adding to the structural heart toolbox for the interventional cardiologist, has …See details»
Millipede Announces Peer Reviewed Publications - BioSpace
Oct 30, 2017 · Millipede, Inc. (www.millipedemedical.com) is a medical device company based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in heart …See details»
Early experience with Millipede IRIS transcatheter mitral annuloplasty
Oct 5, 2018 · The Millipede IRIS annuloplasty ring (Millipede, Inc., Santa Rosa, CA, USA) is a semi-rigid, complete (i.e., closed) ring that is made from laser-cut and heat-set nickel-titanium …See details»
Perfuze’s Millipede Aspiration and Access ... - Endovascular Today
December 20, 2023—Perfuze announced that the second generation of its Millipede 088 access catheter and its Millipede 070 aspiration catheter have received FDA 510 (k) clearance. The …See details»
Millipede, Inc. Announces First Cases with 50mm Transcatheter ...
Jul 24, 2017 · Millipede, Inc. (www.millipedemedical.com) is a medical device company based in Santa Rosa, California with the goal of providing catheter delivery of the gold standard in heart …See details»
Perfuze enrols first patient in stroke trial with its Millipede system
Nov 2, 2023 · Perfuze has enrolled the first patient in the MARRS pivotal study evaluating the performance and safety of its Millipede system for the treatment of acute ischemic stroke. …See details»
Millipede, Inc. Announces Peer Reviewed Publications - PR Newswire
SANTA ROSA, Calif., Oct. 29, 2017 /PRNewswire/ -- Millipede, Inc., a leader in device innovations for mitral and tricuspid disease, today announced the release of two peer …See details»